Showing results (201-210 of 264) with videos related to
Sort By:
Pageof 27
Plos One|September 23, 2021
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence: Navigating the absence of a gold standardSahar Saeed, Sheila F O'Brien, Kento Abe, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 23, 2020
Development of an Ordinal Scale Treatment Endpoint for Adults Hospitalized With InfluenzaNelson Lee, Stephanie W Smith, David S C Hui, et al.Journal of Clinical Microbiology|October 23, 2009
Multicenter comparison of two norovirus ORF2-based genotyping protocolsKirsten Mattison, Elsie Grudeski, Brian Auk, et al.Transfusion|March 24, 2026
Using blood donor surveillance and clinical case data to shape our understanding of Babesia epidemiology in Manitoba, CanadaSteven J Drews, Carmen L Charlton, Sandra Ramirez-Arcos, et al.Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 3, 2016
Mutations acquired during cell culture isolation may affect antigenic characterisation of influenza A(H3N2) clade 3C.2a virusesDanuta M Skowronski, Suzana Sabaiduc, Catharine Chambers, et al.The Journal of Infectious Diseases|October 14, 2017
Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015-2016 Season in CanadaDanuta M Skowronski, Catharine Chambers, Suzana Sabaiduc, et al.Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 30, 2016
Interim estimates of 2015/16 vaccine effectiveness against influenza A(H1N1)pdm09, Canada, February 2016Catharine Chambers, Danuta M Skowronski, Suzana Sabaiduc, et al.Access Microbiology|December 11, 2023
Eleven-month SARS-CoV-2 binding antibody decay, and associated factors, among mRNA vaccinees: implications for booster vaccinationMichael Asamoah-Boaheng, Brian Grunau, Scott Haig, et al.Microbiology Spectrum|June 8, 2023
Diminished Neutralization Capacity of SARS-CoV-2 Omicron BA.1 in Donor Plasma Collected from January to March 2021Yi-Chan J Lin, David H Evans, Ninette F Robbins, et al.Microbiology Spectrum|January 10, 2023
Cross-Canada Variability in Blood Donor SARS-CoV-2 Seroprevalence by Social Determinants of HealthSheila F O'Brien, Niamh Caffrey, Qi-Long Yi, et al.Pageof 27